Is Tylenol's safety now in question? Crisis grips Johnson & Johnson.
Johnson & Johnson faces scrutiny over Tylenol manufacturing. Recent FDA inspections revealed serious issues. These problems involve data integrity and quality control. The Wall Street Journal broke the story, sparking widespread concern.
The FDA found significant lapses at a Pennsylvania plant. Specifically, they cited failures to investigate manufacturing deviations. Over 200 quality control issues were reportedly uncovered. This impacts production of several Tylenol formulations.
Johnson & Johnson stated they are addressing the findings. They claim to be working with the FDA to resolve the problems. The company insists patient safety remains their top priority.
This situation could lead to recalls and supply chain disruptions. Further investigations are expected to determine the full scope. The incident highlights the importance of pharmaceutical quality assurance.
